NCT02293954 Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT02289898 Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT02284139 Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects Status COMPLETED Phase PHASE2/PHASE3
NCT02283372 Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02278458 Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer Status UNKNOWN Phase PHASE1
NCT02277834 Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice Status COMPLETED Phase N/A
NCT02272738 A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02260128 Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery Status UNKNOWN Phase NA
NCT02246322 A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions. Status UNKNOWN Phase NA
NCT02245217 Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients Status COMPLETED Phase NA
NCT02241187 Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection Status COMPLETED Phase NA
NCT02237157 A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02210364 Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC). Status COMPLETED Phase PHASE1
NCT02209415 EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer Status UNKNOWN Phase NA
NCT02208024 Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body Status COMPLETED Phase NA